Artificial Intelligence (AI) continues to transform various scientific fields through extraordinary innovations and cutting-edge discoveries. The integration of AI in ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

The U.S. Food and Drug Administration plans to integrate generative artificial intelligence across all its centers by June 30, 2025, following a successful pilot program. Here are five things to know: ...

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...

Unchecked AI agency is exactly what poses the greatest threat to public safety. So my team and I are forging a new direction ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

SANTA CLARA, Calif.– Cadence today announced the Millennium M2000 Supercomputer featuring NVIDIA Blackwell systems, for ...

The FDA is looking into how AI could help with final drug approvals and improve internal tasks like checking whether an ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to permanent cracks in the increasingly fragile research ecosystem, ...

The company assists clients across multiple industries, including pharmaceuticals, in their research and development ... and improving the drug discovery process. Absci Corp, supported by a strategic ...

Although gene-editing and other techniques can improve the production of microbe-based biologics, AI could push these drugs ...